Chun Chin Chang

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study

Ya‐Wen Lu, Chun Chin Chang, Ruey‐Hsing Chou et al. · Cardiovascular Diabetology · 2021 · 157 citations · Full text

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon et al. · European Heart Journal · 2019 · 119 citations · Full text

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak et al. · JACC: Cardiovascular Interventions · 2019 · 110 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Clinical Implication +10

Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial

Azfar Zaman, Robbert J. de Winter, Norihiro Kogame et al. · The Lancet · 2019 · 94 citations

Percutaneous Coronary Intervention, Atherosclerotic Lesions, Endovascular Technique +9